CD274 and inborn error of immunity: In this study, we chose LVs as a delivery system for human PD-L1 targeting sdAbs, as LVs were previously shown to efficiently deliver their cargo to mainly tumor cells upon intratumoral delivery,31 and because LVs have been used in a clinical setting for therapy for primary immunodeficiencies and cancers.32